TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
FBRX

Forte Biosciences Inc

Healthcare · Biotechnology

77.00$ +0.0% vs. previous close Closing price · As of: Aug 28, 2026

Ownership

Ownership Structure

Who owns Forte Biosciences Inc (FBRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.9% of the shares are freely tradable; institutional investors hold 74.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 74.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 87.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 7.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 21Mio.

Largest Shareholders

Institutions

Institutions FBRX
Name Stake (%) Shares Change (%) Date
Federated Hermes Inc 9.94 2,110,516 +19.5 06/30/2026
Fred Alger Management, LLC 6.00 1,273,965 -12.8 03/31/2026
Orbimed Advisors LLC 5.64 1,196,955 +0.0 03/31/2026
HHG PLC 5.60 1,188,060 -16.7 03/31/2026
Affinity Asset Advisors, LLC 5.40 1,145,391 +13.2 06/30/2026
MPM Oncology Impact Management LP 4.65 987,448 -1.3 06/30/2026
TCG Crossover Management, LLC 4.33 920,000 +0.0 06/30/2026

Funds

Funds FBRX
Name Stake (%) Shares Change (%) Date
Federated Hermes Kaufmann R 5.90 1,251,500 +20.2 06/30/2026
Federated Hermes Kaufmann Growth 5.90 1,251,500 +20.2 06/30/2026
Fidelity Select Biotechnology 4.36 924,891 +84.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 27, 2026 Kornfeld Steven Director Other 3,960 – –
Aug 27, 2026 Wagner Paul A. SEE REMARKS Other 85,482 – –
Aug 27, 2026 Riley Antony A CHIEF FINANCIAL OFFICER Other 42,600 – –
Aug 27, 2026 Gryska David W Director Other 5,940 – –

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?